Antiphospholipid Syndrome
📧 Sign up to get email alerts when something new happens for Antiphospholipid Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Daratumumab in Primary Antiphospholipid Syndrome [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating daratumumab for primary antiphospholipid syndrome. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]
Phase 1b long-term extension trial of RAY121 in multiple immunological diseases is currently enrolling by invitation, expanding early-phase …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy [Phase 2]
A Phase 2 study (IMPACT) is evaluating certolizumab pegol to improve pregnancy outcomes in antiphospholipid syndrome during high-risk pregna…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]
Phase 1 trial update on YTS109 cell therapy for relapsed/refractory autoimmune diseases, currently recruiting across multiple indications.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 in pediatric relapsed/refractory autoimmune diseases, including SLE and diffuse systemic sclerosi…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients
An observational study is evaluating the effectiveness of direct oral anticoagulants for secondary thrombosis prevention in low-risk antipho…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases [NA]
This clinical trial is recruiting to evaluate anti-CD19 IL-10/IL-15 CAR-NK cells for refractory/relapsed autoimmune diseases. Conditions inc…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
This registry from McMaster University aims to evaluate augmented antithrombotic treatment regimens for patients with antiphospholipid syndr…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
A pediatric antiphospholipid syndrome trial (NCT00616317) sponsored by the University of California, Davis is currently recruiting internati…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
This clinical trial aims to characterize autoreactive B lymphocytes in autoimmune diseases and immune deficiencies. The study status is not …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) [NA]
This clinical trial update indicates ongoing recruitment for a study examining the prevalence and consequences of antiphospholipid syndrome …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
A completed clinical trial registry entry for patients with antiphospholipid syndrome and/or systemic lupus erythematosus, sponsored by Assi…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome [NA]
This clinical trial update describes an ongoing study evaluating the expression of Annexin A2 on monocytes in primary antiphospholipid syndr…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Follow-up Cohort of Patients With Antiphospholipid Syndrome
This clinical trial update describes a follow-up cohort study in Antiphospholipid Syndrome, with participant recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
A clinical trial update investigating whether hematological markers MPV, PLR, and NLR differ between primary and secondary antiphospholipid …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases [Phase 1, Phase 2]
This clinical trial update describes a phase 1/2 study evaluating universal CD19-targeting CAR-γδT cells for refractory autoimmune diseases,…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Pilot Study of Gut Commensals in Antiphospholipid Syndrome
A pilot study evaluates gut commensal bacteria in antiphospholipid syndrome; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Hematological Disorders in EHPVO Patients
A clinical trial update describes a study on hematological disorders in patients with Extrahepatic portal vein obstruction and thrombophilia…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Anti-CD38 Antibody Treating APS With Thrombocytopenia [Phase 2]
A Phase 2 clinical trial evaluating an anti-CD38 antibody for antiphospholipid syndrome with thrombocytopenia is currently recruiting in Chi…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia [Phase 4]
A Phase 4 clinical trial is evaluating sirolimus as a monotherapy for antiphospholipid antibody-related thrombocytopenia. The study is curre…